Cambridge Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$30 Hold
2
﹤0.01% 654
2023
Q4
$43 Hold
2
﹤0.01% 686
2023
Q3
$37 Hold
2
﹤0.01% 707
2023
Q2
$51 Hold
2
﹤0.01% 692
2023
Q1
$52 Hold
2
﹤0.01% 758
2022
Q4
$0 Hold
2
﹤0.01% 883
2022
Q3
$0 Sell
2
-100
-98% -$3.51K ﹤0.01% 899
2022
Q2
$3K Sell
102
-825
-89% -$35K ﹤0.01% 791
2022
Q1
$67K Buy
927
+719
+346% +$51.8K ﹤0.01% 491
2021
Q4
$19K Buy
+208
New +$24.9K ﹤0.01% 698

Other funds holding TDOC

Cambridge Trust's TDOC Position: Q1 2024 in Review

Cambridge Trust held its Teladoc Health (TDOC) position steady in Q1 2024 at 2 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Cambridge Trust first reported a position in TDOC in Q4 2021 and has held it in 10 quarters since. The position peaked at $67K in Q1 2022. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Cambridge Trust held 2 shares of Teladoc Health worth $30 as of Q1 2024.
  • Cambridge Trust left its Teladoc Health share count unchanged in Q1 2024.
  • Teladoc Health made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #654 holding.
  • Cambridge Trust first reported a position in Teladoc Health in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Teladoc Health position peaked at $67K in Q1 2022.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.